PRICE T ROWE ASSOCIATES INC /MD/ - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$1,749,070,000
+11.7%
8,937,962
-3.0%
0.20%
+2.5%
Q2 2020$1,565,665,000
+45.4%
9,214,128
-1.3%
0.20%
+15.9%
Q1 2020$1,077,069,000
-4.1%
9,334,971
-5.0%
0.17%
+16.4%
Q4 2019$1,122,951,000
+45.0%
9,828,030
+8.4%
0.15%
+32.7%
Q3 2019$774,379,000
+36.4%
9,067,673
+10.5%
0.11%
+37.5%
Q2 2019$567,764,000
-4.2%
8,203,502
+1.3%
0.08%
-8.0%
Q1 2019$592,856,000
+29.6%
8,094,701
+0.2%
0.09%
+13.0%
Q4 2018$457,515,000
-41.5%
8,074,740
-20.4%
0.08%
-32.5%
Q3 2018$782,286,000
+11.5%
10,143,751
-4.0%
0.11%
+6.5%
Q2 2018$701,815,000
+37.8%
10,571,099
+8.6%
0.11%
+32.1%
Q1 2018$509,372,000
+22.1%
9,731,991
+24.8%
0.08%
+19.1%
Q4 2017$417,228,000
+116.5%
7,798,646
+120.1%
0.07%
+106.1%
Q3 2017$192,754,000
-3.1%
3,542,628
-7.9%
0.03%
-8.3%
Q2 2017$198,967,000
-16.0%
3,845,518
+2.1%
0.04%
-18.2%
Q1 2017$236,777,000
+25.9%
3,766,728
+5.7%
0.04%
+18.9%
Q4 2016$188,073,000
-26.7%
3,564,006
-25.0%
0.04%
-28.8%
Q3 2016$256,709,000
+72.2%
4,752,993
+28.8%
0.05%
+62.5%
Q2 2016$149,112,000
+15.0%
3,689,989
-0.2%
0.03%
+14.3%
Q1 2016$129,691,000
-17.6%
3,695,953
+5.4%
0.03%
-15.2%
Q4 2015$157,325,000
+16.4%
3,505,470
-0.0%
0.03%
+10.0%
Q3 2015$135,187,000
+2.7%
3,505,876
+28.9%
0.03%
+11.1%
Q2 2015$131,660,000
+38.5%
2,720,256
+1.1%
0.03%
+35.0%
Q1 2015$95,076,000
+98.9%
2,689,572
+80.8%
0.02%
+100.0%
Q4 2014$47,789,000
-45.0%
1,487,354
-36.4%
0.01%
-47.4%
Q3 2014$86,913,000
-10.3%
2,337,624
-7.7%
0.02%
-9.5%
Q2 2014$96,879,000
-25.2%
2,532,789
-10.9%
0.02%
-27.6%
Q1 2014$129,445,000
-34.1%
2,841,203
-42.3%
0.03%
+26.1%
Q4 2013$196,574,000
+90.1%
4,927,886
+108.8%
0.02%
-11.5%
Q3 2013$103,421,000
-32.0%
2,359,600
-51.2%
0.03%
+30.0%
Q2 2013$152,066,0004,833,6000.02%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,365,840,00020.68%
Lagoda Investment Management, L.P. 398,529$20,620,0007.88%
Matrix Capital Management Company, LP 2,118,000$109,585,0003.72%
Ghost Tree Capital, LLC 300,000$15,522,0003.23%
Sio Capital Management, LLC 100,000$5,174,0002.46%
GREAT POINT PARTNERS LLC 249,500$12,909,0002.31%
Redmile Group, LLC 665,139$34,414,0002.10%
Eventide Asset Management 525,000$27,164,0001.69%
Opus Point Partners Management, LLC 35,093$1,816,0001.66%
Boxer Capital, LLC 125,000$6,468,0001.54%
View complete list of SEATTLE GENETICS INC shareholders